A Study of Ocrelizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA)

Clinical trial NCT02720120 · TERMINATED

Trial details

NCT number: NCT02720120
Sponsor: Hoffmann-La Roche
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2005-10-01
Primary completion: 2013-02-01
Enrollment: 175

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.